These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1818494)

  • 41. Leukotrienes: role in cardiovascular physiology.
    Letts LG
    Cardiovasc Clin; 1987; 18(1):101-13. PubMed ID: 3038323
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mediators of anaphylaxis.
    O'Flaherty JT; Wykle RL
    Clin Lab Med; 1983 Dec; 3(4):619-43. PubMed ID: 6197225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathways of oxygen utilization by stimulated platelets and leukocytes.
    Marcus AJ
    Semin Hematol; 1979 Jul; 16(3):188-95. PubMed ID: 225828
    [No Abstract]   [Full Text] [Related]  

  • 44. Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils.
    Fiore S; Romano M; Serhan CN
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():93-6. PubMed ID: 1825593
    [No Abstract]   [Full Text] [Related]  

  • 45. Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitro.
    Marcus AJ; Broekman MJ; Safier LB; Ullman HL; Islam N; Sherhan CN; Rutherford LE; Korchak HM; Weissmann G
    Biochem Biophys Res Commun; 1982 Nov; 109(1):130-7. PubMed ID: 6297472
    [No Abstract]   [Full Text] [Related]  

  • 46. Platelet-dependent modulation of neutrophil function.
    Bazzoni G; Dejana E; Del Maschio A
    Pharmacol Res; 1992; 26(3):269-72. PubMed ID: 1437991
    [No Abstract]   [Full Text] [Related]  

  • 47. Synthesis and structure elucidation of leukotrienes.
    Marfat A; Corey EJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 14():155-228. PubMed ID: 2992244
    [No Abstract]   [Full Text] [Related]  

  • 48. Platelet function and platelet-polymorphonuclear-neutrophil interaction in patients with deficient platelet lipoxygenase activity.
    Okuma M; Kanaji K; Sugiyama T; Sensaki S; Uchino H
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():533-6. PubMed ID: 2936163
    [No Abstract]   [Full Text] [Related]  

  • 49. [Sulfidopeptide leukotrienes and asthma].
    Dinh Xuan AT; Peiffer C; Marsac J; Lockhart A
    Rev Mal Respir; 1989; 6(6):483-91. PubMed ID: 2557653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Leukotrienes].
    Dobrosotskaia LV; Shcherbak IG
    Ukr Biokhim Zh (1978); 1984; 56(4):452-60. PubMed ID: 6093306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mediators and the mechanism of their release.
    Lichtenstein LM
    Chest; 1978 Jun; 73(6 Suppl):919-26. PubMed ID: 209948
    [No Abstract]   [Full Text] [Related]  

  • 52. Neutrophils inhibit platelet reactivity by multiple mechanisms: relevance to thromboregulation.
    Marcus AJ
    J Lab Clin Med; 1990 Aug; 116(2):138-9. PubMed ID: 2394936
    [No Abstract]   [Full Text] [Related]  

  • 53. Platelets enhance Fc(gamma) receptor-mediated phagocytosis and respiratory burst in neutrophils: the role of purinergic modulation and actin polymerization.
    Zalavary S; Grenegård M; Stendahl O; Bengtsson T
    J Leukoc Biol; 1996 Jul; 60(1):58-68. PubMed ID: 8699124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipoxin formation: evaluation of the role and actions of leukotriene A4.
    Serhan CN; Sheppard KA; Fiore S
    Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():54-62. PubMed ID: 2169183
    [No Abstract]   [Full Text] [Related]  

  • 55. Phospholipase A2 (PLA2) release leukotrienes and other lipoxygenase products from endogenous sources.
    Lam BK; Wong PY
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():598-601. PubMed ID: 2526544
    [No Abstract]   [Full Text] [Related]  

  • 56. Enzymatic reactions of leukotriene biosynthesis in human polymorphonuclear leukocytes.
    Sun FF; McGuire JC; Kane K; Feinmark SJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():181-3. PubMed ID: 2936088
    [No Abstract]   [Full Text] [Related]  

  • 57. [Leukotrienes and inflammation].
    Borgeat P; Picard S; Poubelle P; Sirois P; Rola-Pleszczynski M; Braquet P
    Union Med Can; 1985 Aug; 114(8):611-7. PubMed ID: 2997964
    [No Abstract]   [Full Text] [Related]  

  • 58. Hyperoxic lung damage in mice: appearance and bioconversion of peptide leukotrienes.
    Smith LJ; Shamsuddin M; Anderson J; Hsueh W
    J Appl Physiol (1985); 1988 Mar; 64(3):944-51. PubMed ID: 2835352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative changes of hydroxyacid formation during platelet-neutrophil interaction.
    Maderna P; Colli S; Caruso D; Eligini S; Toia A; Galli G; Tremoli E
    J Lab Clin Med; 1993 Mar; 121(3):406-14. PubMed ID: 8383163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Icosanoid production during platelet-neutrophil interactions.
    Marcus AJ; Safier LB; Ullman HL; Broekman MJ; Islam N; Oglesby TD; Gorman RR; Ward JW
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():527-32. PubMed ID: 2936161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.